Search Results - "WISTINGHAUSEN, Birte"
-
1
Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature
Published in Pediatric transplantation (01-12-2011)“…Miloh T, Arnon R, Roman E, Hurlet A, Kerkar N, Wistinghausen B. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ…”
Get full text
Journal Article -
2
Clinicopathologic Spectrum of Pediatric Posttransplant Lymphoproliferative Diseases Following Solid Organ Transplant
Published in Archives of pathology & laboratory medicine (1976) (01-09-2024)“…Posttransplant lymphoproliferative disorder (PTLD) remains a significant complication in pediatric patients undergoing solid organ transplant (SOT). The…”
Get full text
Journal Article -
3
Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults
Published in Best practice & research. Clinical haematology (01-03-2023)“…Post-transplant Lymphoproliferative Disease (PTLD) remains a major complication of solid organ transplantation (SOT) in pediatric patients. The majority are…”
Get full text
Journal Article -
4
Pediatric Cutaneous T‐Cell Neoplasms: Clinical and Pathological Features, Updated Classifications, and Critical Differential Diagnoses
Published in Pediatric dermatology (03-11-2024)“…Cutaneous T‐cell lymphoid neoplasms in childhood are exceedingly rare, presenting with a wide spectrum of clinical presentation and outcomes. Due to numerous…”
Get full text
Journal Article -
5
Management of post-transplant lymphoproliferative disorders
Published in Current opinion in pediatrics (01-02-2017)“…Post-transplant lymphoproliferative disease (PTLD) is a major complication of hematopoietic stem cell and solid organ transplantation. The incidence of…”
Get full text
Journal Article -
6
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)
Published in Pediatric blood & cancer (01-11-2019)“…Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of pathologic immune activation, often associated with genetic defects of lymphocyte cytotoxicity…”
Get full text
Journal Article -
7
-
8
Philadelphia chromosome‐like B‐acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation
Published in Pediatric blood & cancer (01-06-2024)Get full text
Journal Article -
9
How I approach B‐lymphoblastic lymphoma in children
Published in Pediatric blood & cancer (01-08-2023)“…There are limited data pertaining to the prognostic features and optimal therapeutic approach for the 20%–25% of children with lymphoblastic lymphoma (LLy) who…”
Get full text
Journal Article -
10
Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy
Published in Journal of child neurology (01-10-2024)“…Here we describe a pediatric patient with febrile infection–related epilepsy syndrome with a good functional and neurologic outcome after treatment with early…”
Get full text
Journal Article -
11
Pediatric cutaneous T‐cell neoplasm and mimics with gamma‐delta expression: Not always aggressive
Published in Pediatric blood & cancer (01-03-2024)“…Pediatric cutaneous T‐cell lymphoma with γδ immunophenotype is extremely rare. Only a few cases of γδ T‐cell neoplasm have been reported in the literature, and…”
Get full text
Journal Article -
12
A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)
Published in Blood (02-11-2023)“…Overview Given the rarity of children and adolescents with relapsed and refractory (r/r) B-cell Non-Hodgkin Lymphoma (B-NHL) and the large number of potential…”
Get full text
Journal Article -
13
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)
Published in Blood (02-11-2023)“…Overview Glo-BNHL is an adaptive prospective international academic-led multicentre platform clinical trial designed to evaluate the efficacy and safety of the…”
Get full text
Journal Article -
14
Post-Transplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients
Published in Pediatric hematology and oncology (01-09-2013)“…Post-transplant lymphoproliferative disease (PTLD) in solid organ transplant (SOT) recipients has become one of the most common forms of lymphoproliferation in…”
Get full text
Journal Article -
15
Fulminant Liver Failure in a Child With β-Thalassemia on Deferasirox: A Case Report
Published in Journal of pediatric hematology/oncology (01-04-2017)“…Deferesirox (DFX), an oral chelating agent, is used to treat chronic iron overload in several hematological diseases such as β-thalassemia, sickle cell…”
Get full text
Journal Article -
16
Children's Oncology Group's 2023 blueprint for research: Non‐Hodgkin lymphoma
Published in Pediatric blood & cancer (01-09-2023)“…Pediatric non‐Hodgkin lymphoma (NHL) includes over 30 histologies (many with subtypes), with approximately 800 cases per year in the United States…”
Get full text
Journal Article -
17
Implementation of a tier system for IVIG indications to address IVIG shortage at a tertiary care pediatric medical center
Published in Pediatric blood & cancer (01-04-2024)“…Background Drug shortages are a common issue that healthcare systems face and can result in adverse health outcomes for patients requiring inferior alternate…”
Get full text
Journal Article -
18
Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults
Published in Pediatric hematology and oncology (06-05-2022)Get full text
Journal Article -
19
Children's Oncology Group's 2023 blueprint for research: Young investigators
Published in Pediatric blood & cancer (01-09-2023)“…The Children's Oncology Group (COG) Young Investigators (YI) Committee is an administrative committee in which liaisons represent 30 COG committees, and was…”
Get full text
Journal Article -
20
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures
Published in Cancer (15-07-2024)“…Langerhans cell histiocytosis (LCH) is a myeloid neoplastic disorder characterized by lesions with CD1a‐positive/Langerin (CD207)‐positive histiocytes and…”
Get full text
Journal Article